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Abstract
Objective—Lower C2, a continuous blood pressure waveform characteristic asserted to represent 
small artery elasticity, predicts future cardiovascular disease (CVD) events. We hypothesized that 
the paradoxical positive association between body mass index (BMI) and C2 may reflect muscle 
instead of excess fat.
Methods—In a multi-ethnic, community living cohort of 1,960 participants, we used computed 
tomography (CT) scans of the abdomen to measure visceral adipose tissue (VAT) and total 
abdominal muscle tissue (TAMT), and used applanation tonometry of the radial arteries to assess 
C2. We then ascertained the period cross-sectional associations between BMI, TAMT, and VAT 
with C2.
Results—The mean age was 62 ± 9 years and 50% male. After adjustments for age, gender, 
ethnicity, pack years smoking cigarettes, diabetes, hypertension, total and HDL cholesterol, higher 
BMI (standardized beta = 0.09, p-value < 0.01) and more TAMT (standardized beta = 0.12, p-
value < .01), were significantly associated with higher C2. In contrast, more VAT (standardized 
beta = -0.09, p-value < .01) was associated with lower C2.
Conclusion—In multivariable analysis, VAT, in contrast to TAMT and BMI was associated with 
less compliant small arteries. Visceral fat may be a better marker for detrimental excess body fat 
than BMI.
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Introduction
Studies investigating correlates and outcomes of excess body fat often use body mass index 
[BMI, weight (kg)/height (m∧2)]. The “obesity paradox” is the observation that being 
overweight with excess body fat may be associated with lower mortality and better 
cardiovascular disease (CVD) outcomes, despite the fact that obesity is a recognized risk 
factor for CVD. This observation initially reported over a decade ago in coronary heart 
disease (CHD) patients undergoing percutaneous coronary intervention, has been 
demonstrated in patients with hypertension, peripheral artery disease (PAD), stroke, 
myocardial infarction (MI), heart failure, and end stage renal disease (HF).(1–5) Moreover, a 
systematic review of 40 cohort studies and 250,152 participants with known CHD, found a 
U-shaped relationship between body mass index (BMI) and CVD mortality, with the lowest 
and highest weight categories exhibiting the highest risk, while the moderate overweight 
category was associated with a lower risk compared to the normal weight group.(6)
Several theories for the obesity paradox have been proposed. First, BMI may indicate lean 
body mass rather than just fat mass. Robero-Corral et al. used body fat percentage (BF%, 
calculated from bioelectrical impedance analysis) as the gold standard to determine the 
accuracy of BMI to identify obesity in men (BF% > 25%) and women (BF% > 35%) in large 
sample representative of the U.S. population.(7) They reported that BMI ≥ 30 had a low 
sensitivity and high specificity to detect obesity in men (46 and 95 percent respectively) and 
women (49 and 99 percent respectively). The also reported that BMI was more strongly 
correlated with lean mass (R2=.44, P-value ≤ 0.01) than body fat percentage (R2=0.53, P-
value ≤ 0.01). Second, others have proposed that BMI may not account for excess central 
fat, which is thought to more adversely affect CVD outcomes than peripheral fat. For 
example, in a meta-analysis of 15,923 (5,696 deaths) participants with CHD, higher central 
fat (measured by waist circumference, and waist-hip ratio) was associated with mortality 
even among individuals with normal BMI.(8) Finally, because BMI doesn't discriminate 
between lean body mass and fat mass, some have proposed that low BMI categories, may 
reflect underlying low muscle mass and poor nutritional status commonly found in chronic 
disease patients.(9)
Notably, most observations of the obesity paradox have been made in patients with chronic 
diseases. In the Multi-ethnic Study of Atherosclerosis (MESA), a cohort of community 
dwelling participants free of clinically manifest CVD at enrollment, a positive association 
was reported between BMI and C2, a continuous blood pressure waveform characteristic 
asserted to represent small artery elasticity.(10) Reduced C2, indicating greater small artery 
stiffness, was an independent predictor of incident hypertension and future CVD events.(10–
12). In this same cohort, compared to the 1st C2 quintile, participants in the 5th quintile were 
at a higher risk of future hypertension (Incident Relative Risk = 2.85, 95% CI: 1.95, 4.16).
(12) Also in this cohort, a per-standard deviation increase in C2 was associated with future 
CVD (HR=0.71, 95% CI: 0.61, 0.83).(10) Given the paradoxical relationship between BMI 
and C2, we conducted analysis that aimed to determine the relationship between computed 
tomographic (CT) measures of abdominal body composition with C2 in an effort to garner 
additional mechanistic insights to factors contributing to the obesity paradox. We 
hypothesized that, independent of BMI and other CVD risk factors, total abdominal muscle 
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tissue (TAMT, rectus abdominus, oblique, psoas, and paraspinal muscles) area would be 
positively associated with C2. In contrast, we hypothesized that, despite the direct 
association of BMI with C2 reported previously, visceral adipose tissue (VAT, intra-
abdominal fat) area would be inversely associated with C2.
Methods
Study sample
MESA is a multi-center, prospective cohort designed to investigate prevalence, correlates, 
and progression of subclinical (asymptomatic) atherosclerosis and their associations with 
incident clinical events. A detailed description of the study design, recruitment methods, 
examination components and data collections has been published.(13) In brief, participants 
included 6,814 men and women (age 45-84) of Caucasian, Hispanic-, African-, and Chinese-
American descent, free from clinically manifest CVD at baseline. Participants were recruited 
between July 2000 and August 2002 at 6 U.S field centers; New York, NY; Baltimore, MD; 
Winston-Salem, NC; St Paul, MN; Chicago IL; and Los Angeles, CA. Signed informed 
consent was obtained for all participants, and institutional review board approval was 
obtained for all participating institutions.
During follow up visits between August 2002 and September 2005, a randomly selected 
subsample of 2202 MESA participants were invited to participate in an ancillary study that 
aimed to determine the presence and extent of abdominal aortic calcium (AAC) using 
computed tomography. Of these, 2172 agreed to participate. Individuals were excluded if 
they were pre-menopausal, or had a recent (within 6 months) abdominal computed 
tomography (CT) scan. This left 1,970 participants who underwent abdominal CT scans. At 
follow-up visits between August 2002 and September 2005, abdominal images were 
obtained using multi-detector CT scanners at Columbia University, Wake Forest University, 
and University of Minnesota field centers (Sensation 64 [Siemens, Malvern, Pennsylvania] 
and GE Lightspeed [GE Healthcare, Waukesha, Wisconsin], Siemens S4 Volume Zoom, and 
Siemens Sensation 16, respectively). Electron-beam CT scanners were utilized at 
Northwestern University and University of California, Los Angeles (Imatron C-150, Imatron 
Inc., South San Francisco, California). Of the 1,970 participants, complete visualization of 
the visceral cavity was available in 1,960 individuals who represent the analytic sample for 
this study.
Central body composition measurements
Among individuals who provided abdominal CT scans, an ancillary study focused on 
abdominal body composition was conducted that interrogated 6 transverse cross-sectional 
slices at and just superior to L4/L5, L3/L4, L2/L3 for different measures of adipose tissue 
and skeletal muscle. Slices centered at L4/L5 junction were selected to quantify TAMT and 
VAT. Lean tissue was identified as being between 0-100 Hounsfield units (HU), and fat 
tissue was identified as -190 and -30 HU. TAMT was defined by adding the area for the 
bilateral rectus abdominus, oblique, psoas, and paraspinal lean tissue area, VAT was defined 
as fat within the visceral cavity. Within each area of interest (TAMT and VAT), we assigned 
the density value assigned to each pixel using the MIPAV 4.1.2 software (National Institutes 
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of Health, Bethesda, Maryland) as fat or lean tissue and then computed the total area (as 
cm2). For all analyses, image analyses were performed by technologists blinded to 
participant clinical information.
C2 measurement
At the baseline visit between 2000 and 2002, arterial waveforms were recorded for the entire 
cohort using the HDI/PulseWave CR-2000 (Hypertension Diagnostics, Inc., Eagan, 
Minnesota). Details of this procedure have previously been published.(10) In brief, a solid-
state pressure transducer array (tonometer) was placed over the radial artery of the dominant 
arm to record the pulse contour. C2 is estimated by the device from the waveform modeled 
as a sinusoidal function dampened by a decaying exponential. An index estimated directly 
from the waveform is divided by systemic vascular resistance (SVR) to obtain C2. SVR is 
estimated as mean arterial blood pressure/cardiac output, and cardiac output is estimated 
from ejection time taken from the pulse waveform, heart rate, age, height, and weight.
Risk factor assessment
Participants were given standardized questionnaires at baseline, which were used to obtain 
information on demographics, medical history, and smoking history. A medication inventory 
was also performed, and medications were grouped based on use to treat high blood 
pressure, or elevated blood glucose. Blood pressure was measured 3 times in the seated 
position with a Dinamap model Pro 100 automated oscillometric sphygmomanometer after 
at least 5 minutes of rest. The average of the last 2 measurements was used. Standard 
measurements were taken for height and weight, and blood samples were obtained after a 
12h fast for measurements of total cholesterol, high-density lipoprotein (HDL) cholesterol, 
and glucose.
Body mass index (BMI) was calculated as weight in kilograms divided by height in meters 
squared. Hypertension was defined as systolic blood pressure ≥ 140 mmHg, diastolic blood 
pressure ≥ 90 mmHg, or current use of anti-hypertensive medication. Diabetes was defined 
as fasting plasma glucose ≥ 126 mg/dL, or use of hypoglycemic medications.
Statistical analysis
This is a period cross-sectional analysis of the 1960 participants with available CT scans of 
the visceral cavity obtained between 2002 and 2005 and C2 measured at the baseline 
examination in MESA approximately 18 and 36 months previously, respectively. Descriptive 
statistics for the study cohort were summarized by means (SD) and ranges for continuous 
variables, and frequencies for categorical variables. Spearman rank correlations of BMI, 
TAMT, and VAT with C2 were calculated. Mean C2 for quartiles of TAMT crossed with 
VAT were determined using ethnic and sex specific cut points. Multivariable stepwise 
backward deletion (p criterion < 0.1) linear regression was used to determine the 
independent association of BMI, TAMT, and VAT with C2. Model 1 adjusted for BMI, 
TAMT, and VAT; model 2 included model 1 plus demographics (age, gender, and ethnicity), 
and traditional CVD risk factors (pack years smoking, diabetes, hypertension, total and HDL 
cholesterol). Variance inflation factor (VIF) was used to test for collinearly among variables 
in both models. Interactions terms, BMI* gender, TAMT* gender, VAT* gender for 
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estimating C2 were also tested in Model 2 (separately). All analyses were conducted using 
PSAW Statistics 18, version 18.0.3 (SPSS, Inc., 2009 Chicago, IL). P-value ≤ 0.05 (two-
sided) was considered significant for all analyses including interaction terms.
Results
Among 1960 participants, the mean age was 62 ± 9 years, 991 (51%) were men, 40% were 
European-, 21 % were African-, 26% were Hispanic- and 13% were Chinese-Americans 
(Table 1). The median [interquartile range] for C2 was 3.8 [2.4 - 5.9 ml/mmHg ×100], mean 
BMI was 28 ± 5 kg/m2, mean TAMT was 123 ± 27 cm2, and mean VAT was 148 ± 69 cm2. 
C2 was correlated with BMI (r = 0.11, P-value < .01), TAMT (r = 0.35, P-value < .01) and 
VAT (r = 0.05, P-value < .05), while BIM was correlated with TAMT (r = 0.37, P-value <.
01) and VAT (r = 0.58, P-value < .01) (not shown). Figure 1 represents mean C2, small 
artery elasticity, by sex and ethnic specific quartiles of TAMT by VAT. Within each VAT 
quartile, we observed higher small artery compliance with increasing TAMT quartile.
Table 2 presents independent associations with C2. In multivariable analysis adjusted for 
age, gender, ethnicity, pack years smoking cigarettes, diabetes, hypertension, total and HDL 
cholesterol, higher BMI and more TAMT were significantly associated with higher C2, 
indicating more compliant small arteries. In contrast, more VAT was associated with lower 
C2. Interaction terms: BMI × gender (Standardized Beta = 0.01, P-value = 1.0); TAMT × 
gender (Standardized Beta = -0.01, P-value = 0.8); and VAT × gender (Standardized Beta = 
0.18, P-value = 0.3) were not significant (not shown). Variance inflation factor among body 
composition measures in fully adjusted models were 1.8 for BMI, 2.5 for TMT, and 1.8 for 
VAT (also not shown).
Discussion
In this study of a multi-ethnic cohort of men and women free of clinically apparent CVD, we 
observed a “BMI-C2 paradox” in a healthy, community-living, older population. 
Specifically, and after adjustment for CVD risk factors, as well as VAT and TAMT, higher 
BMI was associated with increased C2, even though lower C2 is a subclinical marker for 
CVD events. More TAMT was positively associated with higher C2. In contrast to TAMT 
and BMI, more VAT was independently associated with lower C2.
Reduced C2 is a subclinical marker for future CVD.(10) However, BMI, a common clinical 
measure of excess body fat, was positively associated with C2. We hypothesized that VAT, a 
more precise measure of excess fat, especially around the central organs, would be inversely 
associated with C2, while TAMT would be positively associated with C2. We postulated that 
these associations may support the primary theories explaining the “obesity paradox” which 
are that BMI does not discriminate well between lean tissue and excess fat, or between 
peripheral and more harmful central fat.
In support of our hypothesis, more VAT was independently associated with lower C2. Our 
results corroborated a prior study by Sutton-Tyrrell et al. which reported larger VAT area 
was associated with higher aortic pulse wave velocity (aPWV), another subclinical marker 
for CVD and marker of greater arterial stiffness.(14,15) Notably, in that study, investigators 
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did not account for the potential effects of lean muscle tissue on vascular health. Thus, we 
confirm this important finding, and extend the data by demonstrating that associations are 
also evident for small artery elasticity, and independent of the quantity of lean muscle in the 
abdomen.
Also supportive of our hypothesis, more TAMT was associated higher C2. Our findings are 
supported by a prior study of 648 participants, which found lean leg mass, was inversely 
associated with arterial stiffness.(16) Our findings along with others suggest that lean muscle 
mass may be driving the positive association between BMI and favorable cardiovascular 
outcomes. If true, BMI may reflect lean muscle tissue generally thought to have favorable 
effect on vascular health. In a population of participants with known CAD, we have 
previously published results which showed that greater 24 hour urine creatinine excretion (a 
marker of muscle mass)was strongly protective for CVD (17), and these findings have been 
corroborated in the general population.(18) In further support of our hypothesis, BMI 
misclassification of body fat status has been previously reported.(7,19)
Strengths of our study include precise body composition measures from abdominal CT 
scans, a community-living sample, representation of multiple ethnicities and both genders, 
and a relatively large sample size. Also, prevalent CVD at baseline was an exclusion 
criterion, while prior studies have studied the “obesity paradox” in cohorts with prevalent 
CVD. However, our study also has important limitations. First, the non-simultaneity of the 
predictor and outcome measures makes it problematic, even as a period cross-sectional study 
and we cannot assign temporality. However, it is unlikely that these measures would change 
systematically over a short period of time. Second, C2 is a quotient of the pressure 
waveform index and SVR which includes height and weight, components of BMI. However, 
results of sensitivity analysis with C2*SVR were similar but weaker than those for C2. 
Finally, use of abdominal CT slices to quantify areas of fat and muscle tissue may not be the 
best representation of total body fat and muscle composition. Though, abdominal skeletal 
muscle quantified from a single magnetic resonance imaging at L4/L5 is a strong marker for 
whole body skeletal muscle.(20)
Conclusion
In community-living individuals without clinically apparent CVD, greater visceral adipose 
tissue was associated with stiffer small arteries, despite the fact that greater body mass index 
was not. At the same time, greater abdominal muscle was associated with more compliant 
small arteries. The paradoxical association of BMI with compliant arteries may be because it 
is not specific to the type of mass (adipose or lean muscle) or the location of fat (visceral vs. 
peripheral). These findings suggest that lean muscle, instead of excess body fat, may be 
driving the favorable association between BMI and arterial compliance. Studies using more 
refined methods of body composition such as CT for visceral adipose tissue, and 
simultaneous assessment of muscle and fat may provide new insights into seemingly 
disparate relationships of BMI with adverse health outcomes.
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What is already known about this subject?
• Excess fat adversely affects cardiovascular health.
• Being overweight, determined by your body mass index, is associated with 
favorable cardiovascular outcomes.
What does this study add?
• In a healthy, community living population, computed tomography measures of 
visceral fat was independently associated with adverse vascular health after 
adjusting for both BMI and lean muscle tissue.
• Abdominal muscle tissue has favorable effects on vascular health in contrast to 
visceral fat
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Figure 1. Mean C2, small artery elasticity by sex and ethnic specific quartiles of total abdominal 
muscle tissue (TAMT) and visceral adipose tissue (VAT)
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Table 1
Cohort Characteristics
N = 1960 Mean ± SD [Range], N (%)
Age, years 62 ± 9 [44 - 84]
Male sex 991 (51%)
European Ethnicity 787 (40%)
African Ethnicity 410 (21%)
Hispanic Ethnicity 508 (26%)
Chinese Ethnicity 255 (13%)
Body mass index, BMI, kg/m2 28 ± 5 [15 - 53]
Total abdominal muscle tissue, TAMT, cm2 123 ± 27 [62 - 246]
Visceral adipose tissue, VAT, cm2 148 ± 69 [16 - 469]
Pack Years Smoking 12 ± 21 [0 - 187]
Type 2 Diabetes Mellitus 77 (8%)
Hypertension 455 (47%)
Total Cholesterol, mg/dL 196 ± 34 [65 - 462]
HDL Cholesterol, mg/dL 51 ± 15 [21 - 121]
C2, small artery elasticity, ml/mmHg ×100 4.6 + 2.9 [1 - 20.74]
C2 = continuous blood pressure wave form characteristic asserted to represent small artery elasticity
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